A 44-year-old male presented with shortness of breath for 1 year that had progressively worsened. His history included irregular heartbeats, syncope, and a family history of sudden cardiac death in a brother. On examination, he had an irregular pulse of 94 bpm and a heart murmur. An ECG showed asymmetric septal hypertrophy and echocardiogram revealed left ventricular outflow tract obstruction consistent with a diagnosis of hypertrophic cardiomyopathy.
syncope in children , vasovagal syncope , fainting in children , causes of syncope in children , how to manage syncope in children , cardiac syncope , differnetial diagnosis of syncope , approach to syncope
syncope in children , vasovagal syncope , fainting in children , causes of syncope in children , how to manage syncope in children , cardiac syncope , differnetial diagnosis of syncope , approach to syncope
left ventricular hypertrophy, coarcatation of the aorta. contains case discussion, diagnosis, management, discussion, pathophysiology, treatment and labs.
Pulmonary Hypertension Case Discussion - Dr. Shashi Prabha.pptxShashi Prabha Pandey
A case presentation on pulmonary hypertension. This presentation discusses the disease and its management through conventional, yoga, and naturopathic medicine.
Long case examination done during MBBS and MD examination. Neurology case is mostly the long case. History, general examination , systemic examination, provisional diagnosis, investigation and final diagnosis are the sequential steps. Neurology examinations includes higher mental function, cranial nerve examination, motor and sensory system examination, cerebellar signs, gait, peripheral nerves, spine and skull and peripheral nerve examination.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
3. History
A 44-year-old male presented to OPD with
Shortness of breath for 1 year
History
General Physical
Examination
Systemic Examination Investigations Treatment
4. History of Present Illness
• My patient was in his usual state of health 1 year back
when he developed shortness of breath which was
• More on exertion
• Progressive (first he could take stairs, now taking few stairs
causes worsening of SOB)
• Not associated with dyspnea on lying flat or sudden night
wakening due to dyspnea
• Associated with palpitations and chest pain
History
General Physical
Examination
Systemic Examination Investigations Treatment
5. Past
History• He has been admitted in hospital 3 times for syncope
• History of irregular heart beats since last year.
Treatment History
Lisinopril (ACE inhibitor)
Metoprolol 50mg/day
Aspirin 325mg/day
History
General Physical
Examination
Systemic Examination Investigations Treatment
6. • Personal History
• Real state agent
• Smoker
• Addict
• Family History
• Married, 4 Children
• H/O sudden death of brother at the age of 22
• Ischemic Heart Disease
History
General Physical
Examination
Systemic Examination Investigations Treatment
8. General Physical Examination
• A healthy looking man of average height and built is lying
comfortably in bed fully oriented in time, place & person
• Vitals
• Pulse: 94/min
• Blood pressure: 132/82
• Respiratory Rate: 22/min
• Temperature: 98°F
History
General Physical
Examination
Systemic Examination Investigations Treatment
9. • No Pallor, Cyanosis, Clubbing, Koilonychia, Leuconychia,
Splinter Hemorrhage, Pitting of nails.
• No Osler's Nodes, Heberden's Nodes, Bouchard's Nodes,
Joint Swelling, Deformitiy
• No puffiness, xanthalasmas, jaundice, rash, parotid
swelling, proptosis, hirsutism.
• No thyroid swelling, neck veins engorgement, JVP not
raised.
• No lymph nodes palpable. No Edema
History
General Physical
Examination
Systemic Examination Investigations Treatment
11. Cardiovascular System
• Pulse
Pulse is 94/min, regular, normal volume, but jerky with no radio-
radial or radio-femoral delay and vessel wall is not palpable.
• Inspection
No bulging, scars, visible pulsations.
History
General Physical
Examination
Systemic Examination Investigations Treatment
12. • Palpation
Apex beat is palpable in 5th ICS at mid clavicularline and is heaving
in character. No left parasternal heave. No palpable heart sounds.
• Auscultation
Normal first and second heart sound and fourth (S4) heart sound.
Grade 3/6 ejection systolic murmur that increased with the
Valsalva maneuver and decreases wit squatting was best heard in
the third intercostal space left of sternum.
History
General Physical
Examination
Systemic Examination Investigations Treatment
13. Resp. System, GIT and CNS
•Normal
History
General Physical
Examination
Systemic Examination Investigations Treatment
15. Investigations
• ECG
• Echocardiogram
History
General Physical
Examination
Systemic Examination Investigations Treatment
• Asymmetric septal hypertrophy
• Mild systolic anterior motion of mitral valve with LVOT
obstruction was present
• Mild mitral regurgitation is also seen
• Right ventricle was of normal size and function
